1 |
Chaturvedi AK, Udaltsova N, Engels EA, et al. Oral leukoplakia and risk of progression to oral cancer: a population-based cohort study[J]. J Natl Cancer Inst, 2020, 112(10): 1047-1054.
|
2 |
Lyu MY, Guo YS, Li S, et al. Hospital-based epidemiological and clinical characterisation of the malignant transformation of oral leukoplakia in a Chinese population[J]. Int Dent J, 2017, 67(4): 252-259.
|
3 |
Wang TJ, Wang L, Yang HF, et al. Development and validation of nomogram for prediction of malignant transformation in oral leukoplakia: a large-scale cohort study[J]. J Oral Pathol Med, 2019, 48(6): 491-498.
|
4 |
Liu W, Wang YF, Zhou HW, et al. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients[J]. BMC Cancer, 2010, 10: 685.
|
5 |
周红梅, 杨娅, 周敏, 等.口腔黏膜组织结构及DNA损伤修复功能的增龄性变化[J].华西口腔医学杂志, 2003, 21(3): 177-179.
|
6 |
Zhang XY, Hu FL, Liu LH, et al. Effect of silencing of mediator of DNA damage checkpoint protein 1 on the growth of oral squamous cell carcinoma in vitro and in vivo[J]. Eur J Oral Sci, 2019, 127(6): 494-499.
|
7 |
Xie LP, Jia LM, Qu JY, et al. Expression and prognostic significance of the P53-related DNA damage repair proteins checkpoint kinase 1 (CHK1) and growth arrest and DNA-damage-inducible 45 α (GADD45A) in human oral squamous cell carcinoma[J]. Eur J Oral Sci, 2020, 128(2): 128-135.
|
8 |
Rothkamm K, Barnard S, Moquet J, et al. DNA damage foci: meaning and significance[J]. Environ Mol Mutagen, 2015, 56(6): 491-504.
|
9 |
Leung EY, McMahon JD, McLellan DR, et al. DNA damage marker phosphorylated histone H2AX is a potential predictive marker for progression of epithelial dysplasia of the oral cavity[J]. Histopathology, 2017, 71(4): 522-528.
|
10 |
Farah CS, Jessri M, Bennett NC, et al. Exome sequencing of oral leukoplakia and oral squamous cell carcinoma implicates DNA damage repair gene defects in malignant transformation[J]. Oral Oncol, 2019, 96: 42-50.
|
11 |
Chou SJ, Alawi F. Expression of DNA damage response biomarkers during oral carcinogenesis[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2011, 111(3): 346-353.
|
12 |
Slootweg PJ, Eveson JW. Tumours of the oral cavity and oropharynx: introduction[M]// Barnes L, Eveson JW, Reichart P, et al. Pathology and genetics of head and neck tumors. Lyon: International Agency for Research on Cancer Press, 2005: 166-179.
|
13 |
王娟, 戴耀晖, 贾丽华, 等. 口腔黏膜白斑的基因表达谱分析[J]. 中华口腔医学研究杂志(电子版), 2010, 4(6): 590-596.
|
14 |
张德保, 张国栋. 口腔黏膜白斑基因表达谱中重要致病差异表达基因的筛选及分析[J]. 口腔医学研究, 2011, 27(3): 235-237, 240.
|
15 |
陈显久, 刘玮玮, 史培荣, 等. 口腔黏膜白斑(OLK)癌变驱动基因研究[J]. 毒理学杂志, 2011, 25(5): 345-349.
|
16 |
Vodicka P, Vodenkova S, Opattova A, et al. DNA damage and repair measured by comet assay in cancer patients[J]. Mutat Res, 2019, 843: 95-110.
|
17 |
段宁, 王文梅, 蒋红柳, 等. 单核苷酸多态性芯片在口腔白斑癌变监测中的应用[J]. 临床口腔医学杂志, 2012, 28(12): 721-723.
|
18 |
Nikitakis NG, Rassidakis GZ, Tasoulas J, et al. Alterations in the expression of DNA damage response-related molecules in potentially preneoplastic oral epithelial lesions[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2018, 125(6): 637-649.
|
19 |
Tu HF, Chen MY, Lai JC, et al. Arecoline-regulated ataxia telangiectasia mutated expression level in oral cancer progression[J]. Head Neck, 2019, 41(8): 2525-2537.
|
20 |
Zhu MW, Liu W, Shi LJ, et al. Expression of DNA doublestrand repair proteins in oral leukoplakia and the risk of malignant transformation[J]. Oncol Lett, 2018, 15(6): 9827-9835.
|